EIF4EBP1 and Parkinson disease: Using chemogenetic tools or genetic mouse models targeting midbrain dopaminergic neurons to modulate 4E‐BP1/2 levels may provide valuable insights into the mechanisms underlying PD (Bäckman et al. 2006; Lin et al. 2012).